Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710757 · ClinicalTrials.gov registry record · NA
Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
A NA study of Proximal Muscle Strength and Proximal Muscle Lengthening, sponsored by University of Tennessee.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05710757: Active NA study of Proximal Muscle Strength and Proximal Muscle Lengthening, sponsored by University of Tennessee.
NCT05710757 is a NA study of Proximal Muscle Strength and Proximal Muscle Lengthening that is active but no longer recruiting, run by University of Tennessee. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05710757, a NA study of Proximal Muscle Strength and Proximal Muscle Lengthening, is active but no longer recruiting, sponsored by University of Tennessee.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
Conditions Studied
Interventions
- DEVICE blood flow restriction
- OTHER myofascial release
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2024-09 |
| Phase | NA |
What the registry record for NCT05710757 still lists
NCT05710757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Proximal Muscle Strength appearing as the primary indexed condition, and to 2 interventions - of which blood flow restriction is the first listed.
NCT05710757 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05710757 about?
NCT05710757 is a clinical study titled "Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening". The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
What is the current status of trial NCT05710757?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-10-16. Estimated completion is 2024-09.
What conditions does trial NCT05710757 study?
This clinical trial studies the following conditions: Proximal Muscle Strength, Proximal Muscle Lengthening.
What interventions are being tested in trial NCT05710757?
The interventions under investigation include: blood flow restriction (DEVICE), myofascial release (OTHER).
Who is sponsoring clinical trial NCT05710757?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710757 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05710757's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI